Meta Platforms, Inc. (TSX:META)

Ligand Pharmaceuticals Revenue

Meta Platforms had revenue of $42.31B USD in the quarter ending March 31, 2025, with 16.07% growth. This brings the company's revenue in the last twelve months to $170.36B, up 19.37% year-over-year. In the year 2024, Meta Platforms had annual revenue of $164.50B with 21.94% growth.

• Revenue (ttm): $170.36B
• Revenue Growth: +19.37%
• P/S Ratio: n/a
• Revenue / Employee: $2.30M
• Employees: 74,067
• Market Cap: 2,602.23B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	164.50B	29.60B	21.94%
Dec 31, 2023	134.90B	18.29B	15.69%
Dec 31, 2022	116.61B	-1.32B	-1.12%
Dec 31, 2021	117.93B	31.96B	37.18%
Dec 31, 2020	85.97B	15.27B	21.60%